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Abstract. DNA and histone methylation are linked
and subjected to mitotic inheritance in mammals. Yet
how methylation is propagated and maintained be-
tween successive cell divisions is not fully understood.
A series of enzyme families that can add methylation
markstocytosinenucleobases,andlysineandarginine
amino acid residues has been discovered. Apart from
methyltransferases, there are also histone modifica-
tion enzymes and accessory proteins, which can
facilitate and/or target epigenetic marks. Several
lysine and arginine demethylases have been discov-
ered recently, and the presence of an active DNA
demethylase is speculated in mammalian cells. A
mammalian methyl DNA binding protein MBD2 and
de novo DNA methyltransferase DNMT3A and
DNMT3B are shown experimentally to possess
DNA demethylase activity. Thus, complex mamma-
lian epigenetic mechanisms appear to be dynamic yet
reversible along with a well-choreographed set of
events that take place during mammalian develop-
ment.
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Introduction
Enzymaticmodificationsofcytosinebasesandhistone
proteins in the nucleosome core provide heritable
epigenetic information in vertebrates that is not
encoded in the nucleotide sequence of the cell.
Chromatin replication during S phase of the cell
cycle offers a window of opportunity for these
enzymes and accessory factors to load onto the
newly synthesized DNA and robustly propagate all
the modification marks, as found in the parental cells.
Failure to maintain correct epigenetic information
leads to catastrophic consequences for the cell,
including incorrect gene expression and apoptosis
[1–3]. Importantly, cytosine methylation in mamma-
lian cells is faithfully preserved between successive
cell divisions. The preservation of DNA methylation
during cell division is catalyzed by DNA (cytosine-5)
methyltransferases (DNMTs). The major mainte-
nance DNMT enzyme is DNA (cytosine-5) methyl-
transferase 1 (DNMT1) and has strong preference for
hemimethylated DNA in vitro [4]. Previous studies
demonstrate that DNMT1 is stably associated with
newly replicated origin in the mammalian cells [5–7].
Therefore, it is plausible that DNMT1 can methylate
the newly synthesized daughter strands soon after
replication by reading the methylation pattern of the
parental strand [8]. Similarly, there is strong evidence
supporting the heritability of histone modifications in
multicellular organisms. The strongest evidence links
histone H3K27 and H3K4 modification catalyzed by
thePolycombgroup(PcG)andtrithoraxgroup(trxG)
to mitotic inheritance of lineage-specific gene expres-
sion patterns [9]. Although some components of trxG
and PcG possess histone methyltransferase activities * Corresponding author.
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those histonemarks.Thesetwoprotein complexesare
shown to be critical regulators of numerous devel-
opmental genes. They silence or activate a gene via
binding to specific regions of a gene and post-trans-
lationally modifying the histones. Some recent works
have also demonstrated that PcG-mediated gene
silencing may involve non-coding RNA and RNAi
machinery [9]. Thus, the model of histone modifica-
tion inheritance is more complex than DNA methyl-
ation due to replication-independent histone deposi-
tion on DNA [10]. Nevertheless, there is strong
speculation that a large number of histone modifica-
tions may follow epigenetic inheritance mechanisms.
Recent advances in sequencing technology, higher
computational capacity and highly specific antibodies
against histone modifications have resulted in greater
understanding of epigenetic marks in the context of
mammalian genome. The flurry of research activity
has resulted in several very excellent publications
[11–13]. In this review, we have attempted to give
readers a general overview of the epigenetic mecha-
nisms in mammals by discussing histone and DNA
modifications along with the involvement of RNA in
both developmental and biological context.
DNA methylation and its implications in epigenetic
regulation
In the mammalian genome DNA methylation occurs
by covalent modification of the fifth carbon (C
5)i n
the cytosine base and the majority of these modifi-
cations are present at CpG dinucleotides within the
genome. However, in mouse embryonic stem cells,
the genomic DNA contains methylated CpA, CpT
and CpG sequences [14] instead of exclusive CpG
methylation, which is predominately found in so-
matic cells. Nevertheless, 5-methyl cytosine (Me
5C)
accounts for about 1% of total DNA bases and
therefore is estimated to represent 70–80% of all
CpG dinucleotides in the genome [15]. The CpG
dinucleotides are distributed unevenly across the
human genome, but are concentrated in dense
pockets called CpG islands (CGIs). The methylation
pattern in any given cell is the outcome of independ-
ent but dynamic processes of methylation and
demethylation. In the mammalian genome, methyl-
ation patterns in differentiated somatic cells are
generally stable and inheritable. However, reprog-
ramming (demethylation/remethylation) of methyl-
ation pattern takes place during two developmental
stages,in germcells and inpreimplantation embryos.
In contrast to genome-wide demethylation occur-
rence in the primordial germ cells, genomes of
mature sperms and eggs in mammals are highly
methylated as compared to somatic cells [8, 16].
Although the majority of CpGs are methylated in the
genome, CpG dinucleotides within CGI promoters
aretypicallyunmethylatedduringdevelopmentandin
normal (non-neoplastic/non-senescent) tissue types.
The CGIs are genomic DNA regions with high
frequency of CpG dinucleotides. Typically, a CGI is
a region with at least 200 bp with a greater than 50%
GC and an observed/expected CG ratio greater than
60% [17]. Comprehensive analysis of CGIs in human
chromosomes 21 and 22 by Takai and Jones [18]
revealed that regions of DNA of greater than 500 bp
with a G+C equal to or greater than 55%, and
observedCG/expectedCGof0.65weremorelikelyto
be associated with the 5  regions of genes. With this
definition most of the Alu-repetitive elements were
excluded. These islands overlap with promoter re-
gions of 50–60% of human genes [19]. However, a
subset of promoter CGIs are methylated in a tissue-
specific manner during development, showing an
exception to the general rule that CGI methylation
in normal tissue is limited to X-inactivation and
imprinted genes [8, 20]. This observation was sup-
ported further by recent findings of genome-wide
profiling of DNA methylation demonstrating that
non-X-linked promoter CGIs are methylated in
normal tissues and escape methylation in germ line
cells[21].Another studyhasestimated6–8%ofCGIs
tobemethylatedinthegenomicDNAofhumanbrain,
blood, muscle and spleen [22]. Interestingly, in the
same study, CGIs displayed tissue-specific methyla-
tion of genes essential for development, suggesting a
programmed mechanism of DNA methylation. An-
other means of DNA methylation propagation is via
methylation spreading that begins with genome-wide
demethylation that starts shortly after fertilization.
Remethylationofmost ofthegenomeoccursafterthe
blastocyst stage [23] and continues at a slower pace
during the rest of the developmental period. Even
though the phenomenon of spreading has not been
fully understood, it was proposed as a self-perpetuat-
ing interaction between chromatin-modifying pro-
teins and DNA methylation [24]. Indeed, many of the
chromatin modification enzymes responsible for gene
silencing are found associated with each other in
mammalian cells. Some of the examples of DNMT1-
associated proteins are HDAC1 [25], histone methyl-
transferase G9a [26], ATP-dependent chromatin
modeling enzyme SNF2H [27], and Polycomb protein
EZH2 [28]. Therefore, the above hypothesis that
initial DNA or histone methylation will attract
repressive complexes, and create a transcriptionally
unfavorable chromatin conformation is very plausi-
ble. This alteration in chromatin structure, in turn,
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prone to methylation spreading. This phenomenon is
well documented in Arabidopsis, where tandem
repeats upstream of endogene SDC element recruit
non-CG DNA methylation directed by histone meth-
ylation and siRNA, and display spreading of siRNAs
and methylation beyond the repetitive DNA [29].
Existing pieces of evidence in mammalian cells show
that there are certain cis-acting elements that are
dispersed throughout the genome and they can either
act as a methylation signal element or methylation
boundaryduringmethylationspreading.Forexample,
in the mouse Aprt gene, two upstream B1 repetitive
DNA elements were identified to provide de novo
methylation signal for spreading [30]. These elements
reside in the large stretches of DNA dubbed as
methylation centers. Other retrotransposon elements
such as B2, Alu (human equivalent of B1), and LINE-
1 (long interspersed nuclear element-1) are also
considered to possess de novo signaling activity for
methylation spreading [24]. In contrast, the Sp1
binding sites within the Aprt promoter provide the
counteracting force against spreading. Indeed, site-
directed mutation of one or more Sp1 sites eliminates
the binding of transcription factors and allows meth-
ylation to spread at the Aprt promoter [31]. However,
(ATAA)n repeat sequences in the human GSTP1
gene,Sp1andCTCFelementsintheBRCA1gene,act
as boundary elements for prevention of methylation
spreading onto CGIs [32, 33]. Recent experimental
work on genome-wide DNA methylation analysis
discovered an overrepresentation of putative zinc
finger binding sites at the boundaries of methylation-
resistant CGIs. This observation suggested that these
sites may reinforce transcription factor binding and
thereby block methylation spreading and promote
transcription [34]. Dynamic equilibrium between
methylation spreading and its suspension is likely to
be responsible for establishing and maintaining stable
DNA methylation patterns in human somatic cells.
Furthermore, a combined study of bioinformatic
approaches and methylation data from chromosome
21 has demonstrated that DNA sequence, repeat
frequencies,andpredictedDNAstructurescorrelated
with methylation status of CGIs [35].
Aberrant gene expression is one of the key features
associated with complex diseases such as cancer, type
II diabetes, schizophrenia and autoimmune disease.
These diseases are known to be heritable, although
they do not follow clear Mendelian inheritance
patterns. There are several lines of evidence suggest-
ing that epigenetic abnormalities, together with ge-
netic alterations, are responsible for the deregulation
of key regulator genes resulting in these diseases. The
epigeneticmechanismprovides analternative explan-
ation for some of the features in complex diseases,
including late onset, gender effects, parent-of-origin
effects, and fluctuation of symptoms [36]. For exam-
ple, in cancer cells, normally unmethylated CGIs are
often hypermethylated to silence flanking tumor
suppressor genes during neoplasia [37, 38]. On the
other hand, demethylation (hypomethylation) of
normally methylated CGIs can lead to unscheduled
activation of genes, as was first shown at MAGE-1
locus, which is normally expressed only in germ line
cellsbutisactivatedinhumantumors[39].Indeed,the
pattern of cancer-associated methylation of CGIs also
depends on other factors, such as cell lineage and
environmental stimuli. Apart from cancer, a rare
genetic disease ICF (immunodeficiency, centromeric
instability and facial anomalies) syndrome was corre-
lated with methyltransferase machinery. These ICF
patients have mutations in the DNMT3B gene, which
leads to hypomethylation of satellite DNA and
specific chromosomal decondensation [40]. Thus,
DNA methylation and enzymatic apparatus play a
significant role during normal embryonic develop-
ment and diseases.
Histone modification and chromatin function
In eukaryotes, DNA is packaged as chromatin in the
nucleus. Chromatin is further organized into two
different levels of general structure, silent hetero-
chromatin and active euchromatin. Heterochromatin
regionscorrespondtothebulkofnuclearmaterialand
constitute both telomeres and pericentric regions, and
these areas tend to be rich in repetitive sequences and
low in gene content. The rest of the genome is
considered to be euchromatin that contains most of
the genes and is considered transcriptionally active.
The nucleosomes are the basic unit of chromatin
consisting of 147 bp of DNA wrapped around a
histone octamer. Two copies of each of the following
corehistonesarepresentinamononucleosome:H2A,
H2B, H3 and H4. All of them have a globular C-
terminal domain and an unstructured N-terminal tail
[41]. Interestingly, a variety of modifications are
associated with these tails [42]. Histone modifications
include, methylation of arginine (R), methylation,
acetylation, ubiquitination and sumoylation of lysines
(K), and phosphorylation of serine (S) and threonine
(T)(refertothenextsectionandTable 1inthisreview
for detailed description of histone modification en-
zymes and their cognate substrates) [42, 43]. Even
though the significance of most of these modifications
is not fully understood, recent advances in the field
have determined that lysine acetylation and methyl-
ation are key modulator marks for transcriptional
activation or repression [42]. Acetylation/deacetyla-
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and transcription, whereas lysine methylation exerts a
different effect depending on the number of the
methyl groups and position of lysine residues. For
example, modifications that are localized to inactive
genes,suchastrimethylationofH3K9andH3K27,are
often referred to as heterochromatin modifications.
Trimethylation of histone H3 lysine 4 (H3K4) and
acetylation of H3 and H4 are associated with active
transcription and termed as euchromatin modifica-
tions [44, 45]. Plasticity of euchromatin keeps DNA
open for biological activity, thus genes can be tran-
scriptionally turned on or off. A combination of high
levels of acetylation and trimethylation of H3K4,
H3K36, and H3K79 can be detected in transcription-
ally active genes, while low levels of these modifica-
tions are associated with inactive state. However, it
should be noted that acetylation is exclusively asso-
ciated with active chromatin. Most of the acetylated
residues reside in N-terminal tails of histones except
for H3K56, which resides in the core domain [42].
Similar to lysine methylation, arginine methylation
can be either an active or repressive mark for tran-
scription. Indeed, coactivator-associated arginine
methyltransferase CARM1/PRMT4 is physically as-
sociated with histone acetyltransferases and acts in a
cooperativemannermediatingthefunctionofnuclear
factor kB (NF-kB) [46]. Another arginine methyl-
transferase, PRMT5 has been identified to be present
inapromotercomplex,anditisproposedthatPRMT5
may function as a transcription repressor [47]. Sim-
ilarly, histone lysine methyltransferase G9a also
exhibits dual functional specificity acting as both
transcriptional suppressor [48] and activator [49].
Apart from gene expression or repression, chromatin
modification appears to play a vital role in other
cellular processes such as the response to DNA
damage. In response to DNA damage, histone mod-
ificationsmayassistinmarkingthesiteofdamageand
may provide a platform for repair to take place. For
example, phosphorylation of H2A.X variant in re-
sponse to DNA double strand breaks (DSBs), pro-
vides signals for nonhomologous end joining repair
pathway in mammals [50]. Furthermore, methylation
Table 1. Histone-modifying enzymes.
Acetyltransferase Substrates Deacetylases Substrates
HAT1 H4 (K5, K12) SirT2–3 H4K16
GCN5, PCAF H3 (K9, K14, K18) Lysine demethylases Substrates
CBP, P300 H3 (K14, K18), H4 (K5, K8), H2AK5, H2B (K12, K15) LSD1/BHC110 H3 (K4, K9)
TIP60/PLIP H4 (K5, K8, K12, K16), H3K14 JHDM1a-b H3K36
HBO1 H4 (K5, K8, K12) JHDM2a-b H3K9
Lysine
methyltransferases Substrates
JMJD2A/JHDM3A, JMJD2B-
C
H3 (K9, K36)
JMJD2D H3K9
SUV39H1–2 H3K9 JARID1A-D H3K4
G9a H3K9 UTX H3K27
EuHMTase/GLP H3K9 JMJD3 H3K27
ESET/SETDB1 H3K9 Serine/threonine kinases Substrates
CLL8 H3K9 Haspin H3T3
MLL1–5 H3K4 MSK1–2 H3S28
SET1A-B H3K4 CKII H4S1
ASH1 H3K4 Mst1 H2BS14
SET2 H3K36 Rsk2 H3S10
NSD1 H3K36 Ubquitilases Substrates
SYMD2 H3K36 Bmi/Ring1a H2AK119
DOT1 H3K79 RNF20/RNF40 H2BK120
Pr-SET7/8 H4K20 Arginine methyltransferases Substrates
SUV4 20H1–2 H4K20 CARM1 H3 (R2, R17, R26)
EZH2 H3K27 PRMT4 H4R3
SET7/9 H3K4 PRMT5 H3R8, H4R3
RIZ1 H3K9
* Only human enzymes are shown with their substrate histones and the sites of modification. A series of isoforms with the same substrate
specificity are indicated by the name of the enzymes followed by hyphenated numbers or letters.
Cell.Mol.Life Sci. Vol.66, 2009 Review Article 599of H4K20 and cell cycle checkpoint protein Crb2 are
associated with ionizing radiation-induced DNA
damage in fission yeast that results in cell cycle arrest
at G2/M. Similar DNA damage response is also
observed in human cells. For example, mono- and di-
methyl H4K20 are involved in recognition and
recruitment of p53BP1, a homologue of Crb2, to
damaged DNA sites [51].
Recently, a central role of acetyltransferase HBO1
(histone acetyltransferase binding to origin recogni-
tion complex) was demonstrated during DNA repli-
cation [52]. In the above study, HBO1 was found in a
complex with ING family of tumor suppressors that
are associated with cell proliferation. Low levels of
HBO1 and ING5 correlate with reduction in DNA
synthesis and affect progression into S phase [52].
TheseresultssuggestthattheroleofH4acetylationby
HBO1 is an important event for DNA synthesis.
Furthermore,HBO1,ING4,ING5,andp53havebeen
shown to associate in shared protein complexes in
cells. The tumor suppressor p53 physically interacts
with HBO1 and negatively regulates its HATactivity
in vitro and in cells, and thus connects p53-responsive
stress signaling and HBO1-dependent chromatin
modification pathways [53]. Another histone modifi-
cation, phosphorylation may play a role in condensa-
tion/decondensation of chromatin during replication
in mammalian cells. For example, phosphorylation of
H3S10 may function to displace the HP1 complex
fromH3K9methylatedchromatintofacilitatecellular
events for decondensation [54].
In summary, DNA methylation and histone modifi-
cations are important for the coordinated transcrip-
tion, replication and repair process. In all those
complex cellular events, cross-talk between DNA
methylation and histone modifications may help to
maintain correct and ordered recruitment of protein
factors onto chromatin for coordinated function.
Therefore, deregulation of cross-talk(s) can lead to
aberrant outcomes of important biological processes
in living cells.
Enzymes that participate in chromatin modifications
As described before, chromatin modifications in
mammals occur at two distinct levels, DNA methyl-
ation and histone modifications. Several mammalian
DNMTs have been identified, and grouped into two
major classes depending on their substrate preference
and the resulting function (reviewed in [55, 56]).
DNMT3A and DNMT3B are de novo methyltrans-
ferases that are responsible for establishing cytosine
methylation patterns at unmethylated DNA. Global
de novo methylation occurs during early embryo-
genesis when DNA methylation marks are re-estab-
lished after genome-wide demethylation for epige-
netic reprogramming. Once established, DNA meth-
ylation patterns should be stably maintained over cell
divisions. This function is fulfilled by the maintenance
methyltransferase DNMT1 through its preference for
hemimethylated DNA [4, 57], and copying of pre-
existing methylation patterns onto the newly synthe-
sized DNA strands during DNA replication. Further-
more, different isoforms of DNMT1 (Dnmt1 s and
Dnmt1o) participate in maintenance of methylation
imprints in preimplantation mouse embryos [58].
Thus,cooperativefunctionbetweenDNMTsprovides
a way of passing and maintaining epigenetic informa-
tionbetweensuccessivecellgenerations.Thetargeted
deletion of these de novo and maintenance methyl-
transferases results in various developmental defects
[36]. Unlike DNMT1 and DNMT3A/B that contain
both regulatory and catalytic domains, DNA methyl-
transferase DNMT2 has only the catalytic domain
exhibiting only weak methyltransferase activity in
vitro, and its absence causes no discernable effects in
global CpG methylation and developmental pheno-
type [36]. DNMT3L is a DNMT3-related protein that
is expressed only in germ cells and at the stage where
de novo methylation occurs [59]. It lacks enzymatic
activity but modulates the catalytic activity of
DNMT3A and DNMT3B by physically associating
with them. Crystal structures for some of these
mammalian DNMTs (mouse Dnmts) have been
solved, providing additional biochemical and struc-
tural insights into the function of the enzymes [60]. To
date, the available structures include the PWWP
domain of Dnmt3b [61], full-length Dnmt3L with a
bound histone H3 N-terminal tail peptide [62], and a
complex between the C-terminal domains of Dnmt3a
and Dnmt3L [63].
While correct establishment and maintenance of
DNA methylation patterns are critical for normal
development, DNA demethylation is also equally
important for precise execution of developmental
programs as evidenced by epigenetic reprogramming
events in early embryos and primordial germ cells
(PGCs). It is unknown whether DNA demethylation
requires demethylase activities or can occur passively
through DNA replication in the absence of DNMT1.
Although no DNA demethylase activity has been
convincingly identified, several mechanisms have
been proposed to account for the loss of DNA
methylation [64]. For example, DNA deaminases of
the Aid/Apobec family have been shown to catalyze
deamination of 5-methylcytosine resulting in T:G
mismatch, which may lead to DNA demethylation if
the mismatch is repaired [65]. Interestingly, a recent
studyhasproposedthatDNMTsthemselveshavedual
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5-methyl CpGs through deamination during periodic
methylation/demethylation cycles of the pS2 gene
promoteruponactivationbyestrogens[66].Although
precise roles of DNMT3A/B in this process are
unclear, the study has demonstrated that DNMT3A/
B can deaminate both cytosine and 5-methylcytosine
in vitro, and that concordant recruitment of
DNMT3A/B, DNA glycosylase, and other base ex-
cision repair proteins occurs during pS2 promoter
demethylation.
Covalent modifications of histones add multiple
layers of complexity to chromatin, ranging from
small chemical changes such as acetylation and
methylation to large peptide addition such as ubiq-
uitylation and sumoylation. Over the past 10 years,
several families of histone-modifying enzymes have
been identified, as summarized in Table 1. Recent
reviews have extensively covered topics of histone
modifications, their mechanism of action, and the
biological functions derived from individual or com-
bined modifications [42, 67]. Of particular interest,
new nomenclature for some families of chromatin-
modifying enzymes has recently been proposed since
the current nomenclature of the enzymes is rather
inconsistent and often creates additional complexity
[68]. Most histone modifications are dynamically
regulated as evidenced by identification of many
enzymes that can remove the modification. One well-
studied example is histone demethylation that is
carried out by two classes of enzymes, amine oxidases
suchasLSD1andhydroxylasesofJmjCfamily[69].In
contrast, arginine demethylation activity has not been
identified yet, although the deimination process con-
verting an arginine to citrulline has been proposed as
an alternative mechanism to antagonize arginine
methylation [70].
As supported by the number and type of histone-
modifying enzymes (Table 1), lysine has emerged as a
crucial amino acid residue for histone modifications
over the past decade. Interestingly, lysine modifica-
tions of non-histone proteins are also mediated by
some of the known histone-modifying enzymes, and
can be reversed by antagonizing activities just as
observedforhistonemodification.Forexample,lysine
methylation has recently been identified as a novel
modification of the p53 tumor suppressor in addition
topreviouslyknown modificationssuch asacetylation
and ubiquitylation [71]. Histone-modifying enzymes
involved in methylation/demethylation of p53 include
SYMD2, SET9, and LSD1.
In summary, dynamic modifications of DNA/histones
and non-histone proteins by chromatin-modifying
enzymes reflect their functional diversity and regu-
latory complexity.
Other nuclear proteins crucial for epigenetic
modifications
Chromatin modifications can directly change chro-
matin structure by altering the physical properties of
individualnucleosomes,primarilybyneutralizationor
addition of charge to target residues. This affects
histone-DNA interactions and creates either a more
open chromatin architecture or higher-order struc-
tures through differential modulation of internucleo-
somal contacts [67]. In most cases, however, the
epigenetic roles of chromatin modifications are aug-
mented by many specialized sets of nuclear proteins
that do not participate in chromatin modifications per
se but are critical for epigenetic gene regulation.
Among many proteins that fall into this category,
threetypesofproteins/complexesarebrieflyreviewed
in this section: chromatin remodeling complexes,
effector proteins with various binding modules for
different modifications, and insulator proteins.
Chromatin remodeling complexes are energy-driven,
multi-protein machinery that allows access to specific
DNA regions or histones by altering nucleosomal
positions, histone-DNA interactions, and histone
octamer positions (Fig. 1A). These chromatin remod-
ellers have a catalytic ATPase to induce changes in
local chromatin structure covering one or two nucle-
osomes. The ATPases in chromatin remodeling com-
plexes are grouped into three subfamilies: the SWI/
SNF ATPases, the imitation switch (ISWI) ATPases,
and the chromodomain and helicase-like domain
(CHD) ATPases. Several recent reviews have sum-
marized the current understanding of diversity and
specialization of chromatin remodeling complexes
and modulation of remodeller activity by nucleosome
modifications [72, 73].
In many cases, chromatin modifications serve as
recognition sites for the recruitment of effector
modules that read and implement modification-en-
coded biological messages [42, 74]. Several distinct
binding modules have been identified in various
nuclear proteins, coupling a particular histone mod-
ification with cognate effector proteins (Table 2).
Thus, the composition of modifications on a given
histone can either recruit or occlude a set of proteins.
Effector proteins may alter chromatin structure by
binding two or more nucleosomes as found with HP1
and Polycomb group proteins [74]. Effector proteins
can also act as an adaptor to attract additional
chromatin-modifying enzymes or remodeling com-
plexes to augment the chromatin alteration initiated
by the modification. Such an example can be found in
HP1bindingtotrimethylatedH3K9[75]and DNMT1
[76]. These initial interactions can recruit SUV39H1
and/or DNMT1 and promote further H3K9 methyl-
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in turn result in further transcriptional gene silencing
or chromatin repression [77] (Fig. 1B). Similarly, the
PHD domain of BPTF, a component of the NURF
chromatin remodeling complex, recognizes trimethy-
lated H3K4 and brings the remodeller with it [78].
Someothereffectorproteinshaveenzymaticactivities
themselves, as exemplified by CHD1 remodeling
ATPase, which binds to trimethylated H3K4 and
introduces active structure remodeling [42]. Similar
effector proteins have been identified for DNA
methylation. A series of methyl CpG-binding pro-
teins, such as MBDs and MeCP2, has demonstrated
the ability to interpret DNA methylation marks in
different biological contexts (reviewed in [56]). Spe-
cifically, it has been demonstrated that interpretation
ofDNAmethylationmarksbyMBDsandMeCP2has
additional assurance via recruitment of HDACs for
Figure 1. Other nuclear proteins crucial for epigenetic modifications and gene regulation. (A) A simplified example for the role of
chromatin remodeling complexes recruited by transcription factors or specific modifications on chromatin [72]. ATP hydrolysis-driven
repositioningofnucleosomesexposesanoccludedDNAregiontoallowaccessoftranscriptionalmachinery.(B)Modifiedhistonesserveas
recognition sites for effector proteins. The illustration shows that trimethylated H3K9 (hexagons) is recognized by HP1 that recruits
SUV39H1andDNMTstofacilitatefurtherH3K9methylation,HP1binding,andDNAmethylationonadjacentnucleosomes,resultingin
repressive chromatin spreading [75, 76]. (C) A model illustrating two major functions of insulators. Insulators (I) placed between an
enhancer (E) and promoter blocks enhancer-promoter communication, thereby preventing inappropriate activation of promoters by
distant enhancers (left panel). Insulators can also function as a chromatin barrier that limits heterochromatin spreading and prevents
repression of neighboring genes (right panel). Condensed heterochromatin is decorated with repressive marks such as H3K9 methylation
(hexagons) and DNA methylation (circles).
Table 2. Effector proteins containing specific binding modules for histone modifications.
Histone modification Binding modules * Effector proteins (Target histone)
Methylation Chromodomain HP1 (H3K9), PC (H3K27), CHD1 (H3K4)
Tudor JMJD2A (H3K4)
MBT L3MBTL1 (H1bK26, H4K20)
PHD BPTF (H3K4), ING2 (H3K4)
SRA UHRF1 (H3K9)
Acetylation Bromodomain Rsc4 (H3K14), Bdf1 (H4K8), Taf1 (H4K16)
Phosphorylation 14-3-3 14-3-3 protein (H3S10)
*Afewrepresentativeeffectorproteinscontainingthespecifiedbindingmoduleareshownwiththetargethistonemodificationrecognized
by them in parentheses.
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CpG-binding protein UHRF1 has been shown to
recruit DNMT1 itself onto chromatin to facilitate the
faithful inheritance of genomic methylation patterns
[81, 82].
Finally, insulators are DNA elements that can protect
a gene from neighboring transcriptional influences to
prevent inappropriate activation or repression of the
gene. Insulators have two well-known functions that
are represented by enhancer blocking and formation
of chromatin barrier, so that they can either prevent
distal enhancers from activating a promoter or block
heterochromatin spreading that may lead to silencing
of neighboring genes (Fig. 1C). A chromatin insulator
protein CTCF (CCCTC-binding factor) plays impor-
tant roles in many aspects of epigenetic regulation
including genomic imprinting, X-chromosome inacti-
vation, transcription of non-coding RNAs at repeti-
tive elements, and long-range chromatin interactions
(reviewed in [83, 84]). Thus, CTCF-binding sites
establish epigenetic boundaries by which correct
gene expression is ensured during development, and
also contribute to higher-order genome organization
within the nucleus.
Chromatin modification and its role in development
Epigenetic mechanisms can affect long-term gene
expression, which constitutes the basis for the accu-
rate execution of developmental programs and the
maintenance of the cell types over subsequent cell
divisions. PcG and trxG genes were first discovered in
Drosophila melanogaster as master regulators of
homeotic (Hox) gene expression. Polycomb com-
plexes function as repressors of target genes, whose
action is balanced by an antagonistic effect of
trithorax complexes working on the identical DNA
regulatory elements. These elements, PcG or trxG
responseelements(PREs/TREs),recruitPcGortrxG
proteins to form multimeric complexes on PREs/
TREs and mediate epigenetic inheritance of silent or
active chromatin states through cell divisions, respec-
tively. These PcG and trxG complexes are not
required for the initial establishment of homeotic
gene expression pattern, but are essential for main-
tenance of the established state throughout the rest of
development(reviewedin[9]).AlthoughPREs/TREs
have only been identified and characterized in Dro-
sophila, PcG and trxG genes are also conserved in
mammals and play an important role in many devel-
opmental processes such as cell lineage specification
and stem cell maintenance (reviewed in [85]). For
example, recent genome-wide PcG profiling in mouse
and human embryonic stem (ES) cells has revealed
that most PcG targets in ES cells are regulators of
differentiation pathways, suggesting that the PcG
proteins keep stem cells in a pluripotent state by
suppressing cell fate-specific genes [86, 87]. These
PcG target genes can be activated upon differentia-
tion to result in specific cell types with a concomitant
loss of PcG proteins, suggesting a possibility that trxG
proteins may be involved in this activation by replac-
ing PcG proteins on the target genes.
PcG proteins form two distinct multi-protein com-
plexes, Polycomb repressive complex 1 (PRC1) and
PRC2,althoughmammalshavetwoadditionalPRC2-
related complexes. The components of each complex
in different organisms and their recruitment/mecha-
nism of action have been reviewed comprehensively
[88, 89]. The catalytically active component of PRC2,
EZH2, catalyzes trimethylation of histone H3K27,
and this enzymatic activity is required for PRC2-
mediated silencing. The H3K27 methylation mark
deposited by PRC2 recruits PRC1 via its chromodo-
main-containing components, which is believed to
facilitate condensation of chromatin structure. Other
properties of PRC1 also contribute to transcriptional
silencing. PRC1-mediated ubiquitylation of histone
H2A is critical for Hox gene silencing by an unknown
mechanism [90]. In mammalian cells this robust PcG-
mediated repression appears to be stabilized by DNA
methylation since EZH2 can directly recruit DNA
methyltransferases to target genes [28]. Furthermore,
H3K27 methylation by PcG predisposes the marked
genes to de novo methylation leading to aberrant
silencing in cancer cells [91]. Although it remains
unknown inmammaliancells,theremaybeadditional
mechanismsotherthanhistone/DNAmodificationsin
PcG-mediated repression, since studies in Drosophila
have implicated other silencing mechanisms such as
direct interactions with the transcriptional machinery
and transcription of non-coding RNA (ncRNA)
(reviewed in [9]). In fact, PcG complexes have been
shown to participate in gene silencing during X-
chromosome inactivation and genomic imprinting
where ncRNAs play a critical role in silencing
mechanisms, which is reviewed later in this contribu-
tion. As the mechanistic opposite of PcG, trxG
proteins also form several multimeric complexes.
The trxG-associated MLL1 has been shown to cata-
lyze histone H3K4 trimethylation that is recognized
by BPTF, a subunit of NURF chromatin remodeling
complex. This targeting of the remodeling complex to
histones methylated by trxG is thought to facilitate
active chromatin formation by repositioning nucleo-
somes on the promoter [78].
In addition to activation of genomic programs leading
to specific cell types, another equally important
epigenetic event during development is that a cell
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specific to other cell types to secure its fate. The best
example of this lineage restriction is found in neuro-
genesis, during which neural cell fates are acquired in
the developing nervous system, and neuron-specific
genes are repressed in non-neuronal cells outside the
nervous system. This suggests that neuronal chroma-
tin is epigenetically programmed in different cellular
contexts. REST (repressor element 1-silencing tran-
scription factor), a repressor of neuronal genes con-
taining a conserved RE1 provides a link between
epigeneticmechanismsandneurogenesisbyestablish-
ing silent chromatin states in cooperation with other
corepressors and chromatin modifiers (reviewed in
[92]). The corepressor CoREST confers more speci-
alized repression mechanisms, such that the REST-
CoREST complex recruits various chromatin modi-
fiers for long-term silencing of neuronal genes in
terminally differentiated non-neuronal cells. Chro-
matin-modifyingenzymesandotherepigeneticsilenc-
ing factors involved in this process have been exten-
sively reviewed [92].
In contrast to stable and inheritable silencing of
neuronal chromatin in terminally differentiated non-
neuronal cells, the situation in ES cells and neuronal
progenitors impose another aspect of epigenetic
concern on gene expression since these cells should
be able to relieve the silent chromatin state upon
differentiation to allow a lineage-specific gene ex-
pression. A comparative analysis of neuronal gene
chromatin in terminally differentiated fibroblasts and
pluripotent ES cells has revealed that stem cells and
progenitors possess a poised chromatin status for
subsequent neuronal differentiation with distinct
differences in epigenetic marks and transcriptional
features [93]. This study suggests that the core REST
complexestablishescharacteristicchromatinstatesby
recruiting different chromatin modifiers in non-neu-
ronal and ES cells, emphasizing the role of RESTand
its corepressors in building plasticity of neuronal
chromatin.
Taken together, epigenetic mechanisms set a funda-
mental basis for maintenance of ES cell identity and
long-term cellular memory that are crucial for normal
development.
Dosage compensation in mammals
Inmammals,femaleshavetwoXchromosomes(XX),
while males have only one (XY). This chromosomal
differencebetweenthesexescreatesaneedfordosage
compensation systems to adjust the gene dose of X-
linked genes. Mammalian dosage compensation is
accomplished by silencing of one of the two X
chromosomes in females, a process referred to as X-
chromosome inactivation (XCI) (reviewed in [94]). In
mouse and human embryos, XCI is initiated in early
development. The XCI is regulated by a cis-acting
master switch locus, the X-inactivation center (Xic),
which includes ncRNA gene Xist (X inactive specific
transcript) and its antisense transcription unit Tsix/
Xite (Xist spelled backward due to its antisense
orientation to Xist). The Xic senses the number of X
chromosomes and produces the noncoding Xist RNA
from one of the two chromosomes to trigger silencing
in cis. Therefore, the initiation of this random inacti-
vation presents important questions on how cells
count the number of X chromosomes and choose
which one to be inactivated. Recent progress in
understanding the mechanisms driving the XCI
counting and choice has indicated that multiple
regulatory systems may be involved, thus giving rise
to multiple models for the initiation of random XCI
(reviewed in [95]). Among these interesting findings,
trans-interaction of X chromosomes via a novel X-
pairing region of Xic has been observed, suggesting
that the homologous pairing may enable a cell to
detect the number of X chromosomes and coordinate
Xist/Tsix expression to determine the future active
and inactive X chromosomes (Xa and Xi, respective-
ly) [96]. Another recent study supports an alternative
mechanism, a stochastic model where each X chro-
mosomehasanindependentprobabilitytoinitiatethe
XCI within a certain time span. These studies suggest
the presence of a novel X-encoded trans-acting XCI
activator involved in initiation of XCI, based on
observations in tetraploid ES cells [97]. In contrast to
random inactivation, in some mammals the parental
origin determines which X chromosome is to be
inactivated (reviewed in [94]). All tissues of marsu-
pials and the extra-embryonic tissues of mice display
imprintedinactivationofthepaternalXchromosome.
The molecular basis underlying the preferential
paternal X inactivation and the nature of imprints
are not currently well understood.
Once the future Xi is chosen, XCI starts with the
accumulation of Xist RNA along the Xi. The Xist
expression is regulated by the Tsix gene that acts
primarily in the nucleus and is transcribed in the
antisense direction over the Xist gene [98]. The Xist
RNAcoating-inducedsilencingaccompaniesmultiple
layers of epigenetic modifications on the Xi, which
lock in and stably maintain the inactive state through
cell divisions (reviewed in [94, 95]). Chromosome-
wide studies revealed various X-linked histone mod-
ifications, including hypoacetylation of histone H4
[99], trimethylation of H3K9 and H3K27 [100, 101],
H4K20 monomethylation [102], H2AK119 monoubi-
quitylation [103], as well as substitution of core
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[104]. In addition to the histone modification profile,
the Xa and Xi allele-specific DNA methylation
patterns have also been established [105]. Analysis
of Dnmt1
–/– embryos has shown that methylation is
required for stable maintenance of gene silencing on
the Xi [106]. As discussed above, a wide range of
chromatinmodifiersareknowntobeinvolvedinXCI,
including PcG complexes, histone deacetylases, and
DNMT (reviewed in [94]). Although the exact combi-
nation of histone modifications on the Xi may vary
during development and in different lineages and cell
types, the order of chromatin modifications leading to
X inactivation was postulated based on the observa-
tions during female mouse ES cell differentiation
(reviewed in [94, 95]). First, Xist RNA transcription
and accumulation on the Xi in cis trigger silencing
through as yet unknown mechanisms. Then, recruit-
ment of PRC1 and PRC2 mediates H2AK119 mono-
ubiquitylation and H3K27 trimethylation, respective-
ly. At this early stage of XCI, the inactivation process
is reversible and dependent on the presence of Xist
RNA. As cell differentiation proceeds, the Xi under-
goes deposition of histone macroH2A and histone H4
hypoacetylation, followed by promoter-specific DNA
methylation on the Xi. At this phase, the XCI is
irreversible and Xist RNA is not required for main-
tenance of the inactive state. Apart from chromatin
modifications on Xi, the Xi also shows the shift to late
replication during random inactivation [107] and Xist
RNA defines a repressive nuclear compartment early
on in the XCI process [108]. Thus, the epigenetic
marks and temporal/spatial segregation mechanisms
contribute to the initiation and maintenance of XCI.
Despite significant progress in understanding of
molecular mechanisms of XCI, there are still many
unanswered questions. For example, the counting and
choice process of random inactivation awaits further
elucidation of its molecular basis. Similarly, the
mechanisms by which Xist RNA triggers recruitment
of chromatin-modifying complexes remain unknown.
Furthermore, it is still elusive how cis-acting elements
and trans-acting factors coordinate and spread silenc-
ing across the chromosome.
Genomic imprinting
Diploidorganismssuchasmammalscarrytwocopies
of autosomal genes, one from each parent. In most
cases,bothparentalalleleshaveequalpotentialtobe
expressed in cells. However, a subset of autosomal
genesaresubjecttogenomicimprintingbywhichthe
expressionislimitedtooneofthetwoparentalalleles
depending on the parent-of-origin of the gene.
Genomic imprinting is an epigenetic mechanism
conserved in placental mammals, and failure to
establish correct imprinting has been shown to
cause defects in embryonic and neonatal growth
and can result in neurological disorders such as
Prader-Willi syndrome [109]. To date about ~80
imprinted genes have been identified in mice, the
majority of which are clustered in the genome while
there are some solo imprinted genes [110]. Each
imprinted gene cluster often encompasses several
protein-coding genes over 100–3000 kb DNA, and at
least one non-coding RNA (ncRNA) gene [111]. For
example, the maternally imprinted Igf2r cluster
spans ~500 kb, and contains three maternally ex-
pressed protein-coding genes and the 108 kb Air
ncRNA gene that is essential for imprinted gene
expression [112, 113]. Expression of imprinted genes
in each cluster is generally controlled by a single
major cis-acting element, the imprinting control
region (ICR) [114]. ICRs are CpG-rich DNA se-
quences that are methylated in only one of the two
parental gametes, and thus carry the parental in-
formation. This DNA methylation imprint is ac-
quired during gametogenesis. Prior to sex determi-
nation, the parental imprints are erased in germ cells
formed in the embryonic gonad. As the embryo
develops into a male or female, gametic imprints are
placed on paternally imprinted genes during sperm
production and on maternally imprinted genes dur-
ing egg formation, respectively. After fertilization,
this methylation imprint is maintained on the same
parental chromosome through cell divisions. Estab-
lishment and maintenance of the imprints require a
series of epigenetic machinery. Gametic imprints are
established in germ cells by the de novo methyl-
transferase Dnmt3a [115]. Another member of
Dnmt3 family, Dnmt3L, has been shown to be
essential for maternal imprinting in female germ
cells,whereasitsdisruptioninmalegermcellsresults
in meiotic catastrophe caused by retrotransposon
reactivation [116, 117]. These imprinted marks are
stably propagated through successive cell divisions
by maintenance methyltransferase Dnmt1 and its
oocyte-specific isoform Dnmt1o [118, 119]. Further-
more, these gametic imprints can be erased in germ
lines during genome-wide reprogramming by an
unknown demethylation mechanism(s). Although
DNA methylation is the most important mechanism
for imprinting, it does not appear to be the only
mechanism. Histone modification by a mouse PcG
protein Eed has been demonstrated to affect a few
paternally repressed genes; however, it has a rela-
tively minor effect compared to that of DNA
methylationandmayonlycontributetomaintenance
of imprints [120]. Similarly, the absence of histone
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pronounced effects on paternal repression of pla-
centa-specific imprinted genes [121].
As mentioned above, each imprinted gene cluster
contains at least one ncRNA gene that plays a crucial
role in silencing of the multiple protein-coding genes
in the cluster by cis-acting mechanisms. Current
understanding of imprinted gene expression/silencing
has been gained from the studies on six well-charac-
terized clusters, of which four (Igf2r/Air, IC2/Kcnq1,
Gnas, and PWS/AS) are maternally imprinted, and
two (Igf2/H19 and Dlk1) are paternally imprinted by
DNA methylation acquired in the male gamete (as
reviewed in [111]). Despite the differences in gene
organization and ICR functions in different clusters, a
few common features of imprinted gene expression/
silencing can be derived. The unmethylated ICRs are
implicated in all six clusters as positive regulators of
ncRNA expression. In maternally imprinted clusters
(Igf2r/Air and IC2/Kcnq1), the unmethylated ICR
works as a promoter for a paternally expressed
ncRNA that is an antisense orientation to at least
one of the genes in the cluster. While deletion of the
methylated maternal ICR has no effect on maternally
inherited alleles, deletion of the unmethylated pater-
nal ICR reverses the parental-specific expression
pattern such that ncRNA expression is lost and
biallelic gene expression is obtained by abrogation
of paternal silencing. Truncation of ncRNAs at these
loci also has similar effects on paternal gene expres-
sion, relieving silencing of the paternally inherited
alleles (reviewed in [122]). ICRs in paternally im-
printed clusters appear to utilize different mecha-
nisms to control the imprinted gene expression. For
example, the H19 ncRNA at the Igf2/H19 locus is
expressed from the unmethylated maternal chromo-
some but the ICR does not act as a promoter. Rather,
it serves as a boundary element for CTCF (CCCTC-
binding factor) that is a chromatin insulator protein
[83]. The CTCF protein binds the unmethylated
maternalICRblockingthe interaction ofdownstream
enhancers with Igf2 and Ins promoters, while it does
not affect the interaction between the enhancers and
H19 ncRNA promoter. On the paternal chromosome,
the DNA methylation imprint prevents CTCF bind-
ing, thus allowing the enhancers to drive the expres-
sion of Igf2 and Ins genes [123]. Interestingly, the
CTCF protein has been shown to have an additional
functionattheIgf2/H19locus,protectingthematernal
allele from methylation post-fertilization [124].
Although there is an obvious involvement of ncRNAs
in imprinted gene silencing, it is unclear how they can
repress even non-overlapped genes that are several
hundred kilobase pairs apart from either side of the
imprinted ncRNA gene. The major question on this
issue is to determine whether imprinted ncRNAs
silence genes through the transcript itself or through
the action of transcription. Several models have
recently been reviewed to address this question
[122]. Given the similarities in silencing mechanisms
between genomic imprinting and X-chromosome
inactivation many useful insights into imprinting
mechanisms may be obtained by examining whether
what is known about X-chromosome inactivation can
be applied to genomic imprinting. Another important
question that remains unanswered is how the gametic
methylationmachinerydistinguishesparental-specific
alleles and establishes DNA methylation marks at
different regions at different loci.
Inheritance of silent loci and genome defense
Completion of the human and mouse genome se-
quence revealed that transposable elements (TEs)
play a major role in shaping the mammalian genome,
in particular, in its evolution [125, 126]. These
elements account for 45% and 37% of human and
mouse genome, respectively. Families of repetitive
elements include long terminal repeats (LTR)-retro-
transposon, long interspersed nuclear elements
(LINE), short interspersed nuclear elements (SINE),
and DNA transposons.
Retrotransposons transpose with the help of reverse
transcriptase and they can be divided into two
subfamilies depending on the presence or absence of
direct repeats at the end of the element called LTR.
LINE elements do not contain LTRs and account for
17% of the total human genome. A small percentage
of these autonomous non-LTR retrotransposons in
the human genome remain active [127]. Intracisternal
Aparticles(IAPs),MaLRandEtnelementsareactive
LTR retrotransposons present in the mouse genome
[128]. In contrast, SINE elements are non-autono-
mous,non-LTRretrotransposons.TheAlurepeatsare
most common SINE families in human genome and
account for 10% of the whole genome mass [129]. B1
and B2 are major SINE elements in mouse genome
[130]. DNA transposons do not require reverse tran-
scriptase for integration event into the genome.
Instead, a self-encoded protein called transposase
can recognize terminal inverted repeats (TIR) of the
DNAtransposons forgenomeintegration.Todate,no
evidence has been available for the presence of active
DNA transposon, although many copies of inactive
fossil DNA transposons are present [125].
There are many ways that transposable elements can
interfere with the structure and regulation of gene
expression in the genome. They include insertion,
deletion or an inversion of genomic sequences.
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to rearrangements/translocations, and strong constit-
utive promoters of retrotransposons can express
chimeric mRNA [128, 131]. Transposable elements
also can serve as promoters, enhancers, silencers, and
alternative splicing site and thereby modulate the
expression of related genes [132]. In contrast to the
huge number and different modes of gene disruption
associated with these transposons, the damage that
transposons cause to their host is generally minor. For
instance, only 1 in 600 germ line mutations in human
can be attributed to transposon insertions [133]. In
fact, the damage caused by transposons is largely
limited by active repression of these endogenous
parasitic elements. Most transposon copies reside in
heterochromatin,whichbydefinitioncontainsregions
of silent DNA so that they possess little harm to the
host genome.
Mammalian(andothervertebrates)genomestructure
is protected against these parasitic transposable
elements. DNA cytosine methylation and modifica-
tion of histone tails (methylation at H3K9 and
deacetylation) are associated with the host-defense
system [134, 135]. Drosophila suffers from abundant
transposon-mediated mutations and lacks DNA
methylation, which adds supportive evidence to the
above scenario [136]. In mouse, the transcription of
IAP is normally repressed but is greatly induced in
embryos lacking DNMT1, demonstrating that meth-
ylation is responsible for the repressed state of these
elements [137]. Human endogenous retroviruses
(HERVs) resemble simple retroviruses in structure.
The demethylation of HERVs has been examined in a
limited number of cancers (germ cell tumors and
cancers of the ovary, testicles and bladder). In these
cases, HERV hypomethylation increases with malig-
nancy [138]. In vitro transcription assays using site-
specific mutagenesis and methylation demonstrate
that methylation of critical CpG dinucleotides within
the LINE promoter is enough to ensure repression of
transcription. In a number of cancers, hypomethyla-
tion of LINE elements is evident, compared to their
normal counterparts or unaffected adjacent tissues
[139, 140]. LINE hypomethylation can occur early in
cancer initiation, notably in colon and prostate
cancers. In most other cancers studied (leukemias,
urothelial, ovarian and breast cancers), LINE deme-
thylation increases with the degree of malignancy.
Therefore, depending on the cancer type, LINE
hypomethylation may be useful as an early detector
of cancer or a prognostic indicator [141].
Modification of histones also plays a role in suppress-
ing TE transcription. Chromatins associated with TEs
are enriched for methylation of histone H3K9, which
is a signal for transcriptional suppression. Mutation in
Suv39, a H3K9 methyltransferase, leads to reactiva-
tion of TE transcription in mouse ES cells [135]. In A.
thaliana, DDM1 is required for TE silencing. Muta-
tion of ddm1 results in a loss of DNA and H3K9
methylation, also leading to active TE [142]. Lsh1,
mouse homolog of ddm1 is required for TE suppres-
sion, and elevated TE transcripts were observed in
mutant Lsh1
–/– embryos [143].
Another layer of regulation of TE comes with RNA
interference (RNAi) that is mediated through micro-
RNAs (miRNAs). These ~22-nucleotide-long small
RNA molecules can negatively control their target
gene expression. To date there are more than 460
miRNAs documented [144]. Although RNAi-medi-
ated DNA methylation and TE silencing are well
understood for A. thaliana [145], the mechanism by
which RNAi mediates chromatin modification is not
established in mammals. It is known that the DNA
methyltransferase DNMT3A binds to artificially in-
troducedsiRNAanddirectsDNAmethylation,which
is consistent with a requirement of this enzyme in the
downstreameventinRNAi[146].However,complete
understanding of RNAi-regulated epigenetic mecha-
nism in mammals still awaits further investigations.
Future prospects
Research in the last two decades demonstrated an
emerging pattern of cross-talk between different
epigenetic pathways. Some of these pathways were
similar and conserved between both yeast and mam-
malian cells. For example, a cross-talk between RNAi
pathways and histone modification reading protein
Chp1 of yeast is similar to the Xist RNA of the
mammalian cells that plays a role in deposition of
DNA and histone methylation marks for X chromo-
some inactivation, although yeast cells are devoid of
DNA methylation. One of the nagging but difficult
questions in epigenetic mechanisms is the timing of
the events. It is plausible to imagine that chromatin
replication during S phase of the cell cyclemay offer a
greater flexibility for such information to pass from
one generation to next. This hypothesis is supported
by the presence of several complexes of epigenetic
factors such as DNMT1-G9a-PCNA [26], CAF1-
MBD1-SETDB1 [147], DNMT1-HDACs [25, 148]
and the Polycomb protein EZH2-DNMT1 complex
that directs H3K27 methylation [28] during mamma-
lian chromatin replication. However, these observa-
tions do not answer all the questions. Indeed, misloc-
alization of DNMT1 from the replication fork only
had a small effect on the overall genomic methylation
by reducing the methylation efficiency [149]. Perhaps
there are post-replicative chromatin modifications
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matinmodificationduringcelldivision.Currently,itis
not known what roles modified histones play after the
semi-conservative chromatin replication. With the
recent discovery of several histone demethylases that
can erase epigenetic marks, epigenetic modifications
appear to be much more reversible rather than fixed.
This brings us to another challenging area of how
epigenetic marks are erased or rewritten during
development and diseases. These phenomena are
also not understood during ES cell development,
especiallyhowamulti-potentstemcellcangiveriseto
several different cell type, each being genetically
identical but with unique epigenetic signatures and
different cellular phenotypes. Such distinctive epige-
netic phenotypes are hallmarks of adult monozygotic
human twins [150]. Finally, we need a better under-
standing of the molecular phenomenon of epigenetics
in mammalian development and diseases. With mod-
ern technological innovations, such as high-through-
put DNA sequencing, whole genome bisulfite se-
quencing and chromatin immunoprecipitation-se-
quencing, we can explore chromatin modifications in
amoreefficientmanner.Whatweknowtoday isjusta
small percentage of the exciting field of epigenetics.
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